Dexmethylphenidate Hydrochloride

This page contains recent news articles, when available, and an overview of Dexmethylphenidate Hydrochloride but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.

Barr Confirms Patent Challenge of Focalin(R) XR  -  Nov 20, 2007
This action formally initiates the patent challenge process under the Hatch-Waxman Act. Focalin XR (dexmethylphenidate hydrochloride) extended-release CNNMoney.com

Barr Pharma Confirms Patent Challenge Of Focalin XR - Quick Facts ...  -  Nov 20, 2007
...has initiated a challenge of the patents listed for Focalin XR or dexmethylphenidate hydrochloride extended-release capsules, 5mg, 10mg, 15mg & 20mg. RTT News,

Pharmaceutical patent round-up  -  Nov 22, 2007
By Staff Reporter Barr Laboratories has initiated a patent challenge for Focalin XR (dexmethylphenidate hydrochloride) extended-release capsules 5mg, 10mg, In-PharmaTechnologist.com,

Dexmethylphenidate Effective Against Fatigue in Sarcoidosis ...  -  Oct 25, 2007
By John Gever CHICAGO, IL -- October 25, 2007 -- Dexmethylphenidate hydrochloride (d-MPH) can be used to treat fatigue in patients with sarcoidosis, DG News

:

Disclaimer:

Contact a physician with regard to health concerns. Email requests for further health information will be discarded.

The materials contained on this Web site are for informational purposes only and do not constitute health or medical advice. Use of information on this site does not create or constitute any kind of agreement or contract between you and the owners or users of this site, the owners of the servers upon which it is housed, or anyone else who is in any way connected with this site.

Many links on health.mongabay.com lead to other sites. health.mongabay.com does not sponsor, endorse or otherwise approve of the materials appearing in such sites. Nor is health.mongabay.com responsible for dead or misdirected links.